-
Signature
-
/s/ Kevin T. Conroy by Mark R. Busch, attorney-in-fact
-
Stock symbol
-
EXAS
-
Transactions as of
-
Feb 14, 2024
-
Transactions value $
-
-$887,327
-
Form type
-
4
-
Date filed
-
2/16/2024, 06:22 PM
Transactions Table
Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Ownership |
Footnotes |
transaction |
EXAS |
Common Stock |
Award |
$21.3K |
+709 |
+0.06% |
$30.02 |
1.21M |
May 1, 2023 |
Direct |
F1 |
transaction |
EXAS |
Common Stock |
Options Exercise |
$0 |
+31.1K |
+2.58% |
$0.00 |
1.24M |
Feb 14, 2024 |
Direct |
F2 |
transaction |
EXAS |
Common Stock |
Sale |
-$909K |
-14.8K |
-1.19% |
$61.43 |
1.22M |
Feb 15, 2024 |
Direct |
F3, F4 |
holding |
EXAS |
Common Stock |
|
|
|
|
|
27.6K |
Feb 14, 2024 |
Held in 401(k) Plan |
|
holding |
EXAS |
Common Stock |
|
|
|
|
|
21.7K |
Feb 14, 2024 |
Held in Grantor Retained Annuity Trust |
|
holding |
EXAS |
Common Stock |
|
|
|
|
|
21.7K |
Feb 14, 2024 |
Held in Grantor Retained Annuity Trust |
|
holding |
EXAS |
Common Stock |
|
|
|
|
|
21.7K |
Feb 14, 2024 |
Held in Grantor Retained Annuity Trust |
|
Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)
Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Underlying Class |
Amount |
Exercise Price |
Ownership |
Footnotes |
transaction |
EXAS |
Restricted Stock Units |
Options Exercise |
$0 |
-31.1K |
-100% |
$0.00* |
0 |
Feb 14, 2024 |
Common Stock |
31.1K |
|
Direct |
F5, F6 |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.
Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
Explanation of Responses: